Jeito logo.png
Jeito Capital investit dans CatalYm Jeito Capital investit dans CatalYm société biopharmaceutique allemande spécialisée en immuno-oncologie
November 22, 2022 05:00 ET | Jeito Capital
Jeito Capital investit dans CatalYm société biopharmaceutique allemande spécialisée en immuno-oncologie Jeito Capital co-dirige un financement de série C de 50 millions d'euros avec Brandon...
Jeito logo.png
Jeito Capital co-leads EUR 50 million financing in CatalYm, a clinical-stage biopharma company developing novel immunotherapies for patients with cancer
November 22, 2022 05:00 ET | Jeito Capital
                                                            Jeito Capital co-leads EUR 50 million financing in CatalYm, a clinical-stage biopharma company developing novel immunotherapies for patients...
Smart Immune Logo.png
Smart Immune appoints world-class Clinical Advisory Board
November 21, 2022 07:00 ET | Smart Immune
Smart Immune appoints world-class Clinical Advisory Board PARIS, France, November 21, 2022 – Smart Immune SAS, a clinical-stage biotechnology company developing ProTcell™, a pioneering new approach...
Coliving Startup Cohabs Joins Forces With Leading Real Estate Investors to Accelerate Growth
November 18, 2022 15:46 ET | Cohabs
BRUSSELS, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Cohabs, a Brussels-based company specializing in coliving, announces the entry into its capital of three new institutional investors: global real estate...
Jeito logo.png
Jeito Capital réalise son 1er investissement aux Etats-Unis avec HI-Bio, biopharma spécialisée dans la médecine de précision des maladies auto-immunes
November 01, 2022 09:05 ET | Jeito Capital
                                                            Jeito Capital réalise son 1er investissement aux Etats-Unis avec HI-Bio, biopharma spécialisée dans la médecine de précision des maladies...
Jeito logo.png
Jeito Capital becomes a significant investor in HI-Bio, a clinical-stage biotech company developing targeted therapies for patients with severe immune-mediated diseases
November 01, 2022 06:02 ET | Jeito Capital
                                                            Jeito Capital becomes a significant investor in HI-Bio, a clinical-stage biotech company developing targeted therapies for patients with...
BIV_HRZT.png
Big Idea Ventures’ latest cohort of startups enable scale and commercialization for the alternative protein industry
October 04, 2022 08:00 ET | Big Idea Ventures, LLC
NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Big Idea Ventures, global leader in early-stage investments in the alternative protein sector, revealed its latest accelerator cohort today. ...
logo (2).png
The Top 10 Most Visited Capitals Published by Visited
September 20, 2022 04:30 ET | Arriving In High Heels Corporation
TORONTO, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Arriving In High Heels publishes Top 10 most visited capitals as per Travel App's Visited international users. Visited is a travel app that helps keep...
Smart Immune Bolsters Management Team with Medical and Technical Appointments
September 13, 2022 07:00 ET | Smart Immune
Smart Immune Bolsters Management Team with Medical and Technical Appointments Dr Frederic Lehmann, MD, appointed Chief Medical Officer and Dr Pierre Heimendinger, PharmD, appointed Chief Technical...
Ultra-Luxury Diamond Brand Maison Mazerea Launches in Paris
July 13, 2022 10:00 ET | Maison Mazerea
NEW YORK, July 13, 2022 (GLOBE NEWSWIRE) -- Specialising in the rarest Fancy Colour diamonds of irreproachable provenance, Maison Mazerea is the world's first Haute Diamanterie Maison. For its debut...